Lipidor Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 4
Employees
  • Stock Symbol
  • LIPI
Stock Symbol
  • Share Price
  • $1.44
  • (As of Friday Closing)

Lipidor General Information

Description

Lipidor AB is a pharmaceutical development company with a pipeline of drug development projects in preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections and atopic dermatitis.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Karolinska Institutet Science Park
  • Fogdevreten 2
  • 171 65 Solna
  • Sweden
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lipidor Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.44 $1.44 $0.94 - $2.54 $41M 28.4M 283K -$0.07

Lipidor Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 37,167 38,199
Revenue 48 8 28 39
EBITDA (1,596) (1,458) (873) (350)
Net Income (1,596) (1,460) (878) (356)
Total Assets 5,700 3,027 2,023 559
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lipidor Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lipidor‘s full profile, request access.

Request a free trial

Lipidor Executive Team (8)

Name Title Board Seat Contact Info
Ola Holmlund Chief Executive Officer
Olle Holmertz Co-Founder, Board Member and Co-Chief Financial Officer
Michael Owens Chief Financial Officer
Anders Hagman Chief Development Officer
Jan Holmbäck Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Lipidor Board Members (6)

Name Representing Role Since
Fredrik Sjövall Self Board Member 000 0000
Gabriel Haering Ph.D Cerbios-Pharma SA Board Member 000 0000
Magnus Hedman Self Board Member 000 0000
Ola Flink Self Chairman 000 0000
Olle Holmertz Lipidor Co-Founder, Board Member and Co-Chief Financial Officer 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Lipidor Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lipidor Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lipidor‘s full profile, request access.

Request a free trial